In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the future of diagnostics. Later, Eric Hsi, M.D., chair of Mayo Clinic’s Department of Laboratory Medicine and Pathology in Rochester, shares how the department is advancing innovation and helping transform healthcare through laboratory medicine.

• Trends shaping the future of diagnostics (00:31): Dr. Morice discusses the scientific advances, emerging technologies, and evolving patient expectations that are shaping the future of clinical diagnostics.
• Laboratory transformation and innovation at Mayo Clinic (08:20): Dr. Hsi discusses his perspective on laboratory medicine's role in healthcare transformation and how his team approaches innovation across Mayo Clinic.
• Hematopathology advances (18:08): As a leader in hematopathology, Dr. Hsi shares the advances he is most excited about for their ability to improve patient care.

Resources

• ”Answers From the Lab” podcast: Get to Know the DLMP Chair: Eric Hsi, M.D.
• Dr. Bill Morice explores trends transforming diagnostics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Mayo Clinic’s new collaboration with Thermo Fisher and the latest on the Protecting Access to Medicare Act (PAMA). Later, Dr. Pritt welcomes Matt Binnicker, Ph.D., Mayo Clinic Laboratories’ chief scientific officer and a leader in novel diagnostics for viral infections, to explore seasonal virus activity.

• Mayo Clinic and Thermo Fisher collaboration (00:29): Explore how this initiative is turning early biological signals into opportunities for prevention, diagnosis, and treatment.
• PAMA preliminary rates (04:20): Get an overview of CMS's preliminary 2027 Medicare Clinical Laboratory Fee Schedule based on data collected through PAMA.
• Virus update and outlook (08:30): Learn what experts are predicting for seasonal viruses this winter.
• Testing stewardship and innovation (15:43): Discover guidance for seasonal virus testing and how new advances are improving detection.

Resources

• Mayo Clinic News Network: Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear
• CMS: Preliminary Calendar Year (CY) 2027 Medicare Clinical Laboratory Fee Schedule Payment Rates
• Respiratory viruses: Testing for early detection

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.

• Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
• Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
• Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.

Resources

• Survey reveals four strategies for laboratory growth
• Vaccine and immunization guidance from Mayo Clinic
• Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption Webinar
• Bile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrhea
• The right testing for an underrecognized cause of chronic diarrhea